Add to ORKGObjective: Suspected early-onset sepsis is a common diagnosis among neonates which warrants admission to the neonatal intensive care unit. Prolonged empiric antibiotic is the biggest concern and treatment duration is still controversial. Antimicrobial stewardship (AMS) program promotes early antibiotic de-escalation to reduce unnecessary antibiotic exposure and its implementation in the intensive care setting seems to be feasible. The primary objective of this review was to compare the existing guidelines and review the literature regarding choice and duration of empiric antibiotic in managing suspected early-onset neonatal sepsis.Methods: Two Malaysian Ministry of Health guidelines were compared with guidelines from America (n=1), Australi...
\u3cp\u3eBackground Up to 7% of term and late-preterm neonates in high-income countries receive anti...
BACKGROUND Uncertainty about the presence of infection results in unnecessary and prolonged empir...
Background Guidelines from 2005 for treating suspected sepsis in low- and middle-income countries (...
Background Guidelines from 2005 for treating suspected sepsis in low- and middle-income countries (L...
To find out commonly used antibiotic combinations in the management of neonatal sepsis, prevalence o...
This is a retrospective study conducted in three Malaysian General Hospitals to describe the current...
Objective: The aim of this study is to evaluate the antibiotic use in neonates with sepsis.Methods: ...
Background: Antimicrobial therapy for neonatal sepsis is challenging as its judicious use can save n...
Background: Uncertainty about the presence of infection results in unnecessary and prolonged empiric...
Severe infections represent the main cause of neonatal mortality accounting for more than one millio...
BACKGROUND Uncertainty about the presence of infection results in unnecessary and prolonged empiric...
Sepsis is a major cause of newborn death world wide but the burden is heaviest in the developing par...
International audienceUncertainty about the presence of infection results in unnecessary and prolong...
Background Establishing a diagnosis of neonatal sepsis is difficult. As such, appropriate timing of ...
Background: Over used prophylactic antibiotics on the potensially infected newborns to prevent early...
\u3cp\u3eBackground Up to 7% of term and late-preterm neonates in high-income countries receive anti...
BACKGROUND Uncertainty about the presence of infection results in unnecessary and prolonged empir...
Background Guidelines from 2005 for treating suspected sepsis in low- and middle-income countries (...
Background Guidelines from 2005 for treating suspected sepsis in low- and middle-income countries (L...
To find out commonly used antibiotic combinations in the management of neonatal sepsis, prevalence o...
This is a retrospective study conducted in three Malaysian General Hospitals to describe the current...
Objective: The aim of this study is to evaluate the antibiotic use in neonates with sepsis.Methods: ...
Background: Antimicrobial therapy for neonatal sepsis is challenging as its judicious use can save n...
Background: Uncertainty about the presence of infection results in unnecessary and prolonged empiric...
Severe infections represent the main cause of neonatal mortality accounting for more than one millio...
BACKGROUND Uncertainty about the presence of infection results in unnecessary and prolonged empiric...
Sepsis is a major cause of newborn death world wide but the burden is heaviest in the developing par...
International audienceUncertainty about the presence of infection results in unnecessary and prolong...
Background Establishing a diagnosis of neonatal sepsis is difficult. As such, appropriate timing of ...
Background: Over used prophylactic antibiotics on the potensially infected newborns to prevent early...
\u3cp\u3eBackground Up to 7% of term and late-preterm neonates in high-income countries receive anti...
BACKGROUND Uncertainty about the presence of infection results in unnecessary and prolonged empir...
Background Guidelines from 2005 for treating suspected sepsis in low- and middle-income countries (...